Delivery Order SPE2DB20D2014-SPE2DB25FB97V
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,184.02 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $2,964.98 and ultimate completion date of June 2, 2025. This is a non-set-aside competitive award fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,728.46 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $8,518.60 and an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a...
- The Defense Logistics Agency awarded a $8,416.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30. This is a firm fixed price, competitively awarded contract with a completion date of September 22, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The order will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $45,568.20 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in units of 30, with an ultimate completion date of September 18, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,484.21 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 17, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete openly for federal...
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $34,386.90 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger Indefinite...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB97VDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,064.08 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30, with an ultimate completion date of May 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected through open competition to fulfill this medical supply requirement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this IDC framework, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its role as a primary vendor for DOD pharmaceutical procurement across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 5/16/25 |